The challenges and promise of drugs which work (or don’t) based on a patient’s genetic make-up is is discussed in an article recently published in the New England Journal of Medicine. GW faculty Shawneequa Callier and her co-authors describe the market forces and recent litigation which is shaping personalized medicine in this article:
Bonham, V. L., Callier, S. L., & Royal, C. D. (2016). Will Precision Medicine Move Us beyond Race?. The New England journal of medicine, 374(21), 2003.